NASDAQ:ADUS - Addus HomeCare Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $106.33
  • Forecasted Upside: 5.30 %
  • Number of Analysts: 5
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 5 Buy Ratings
  • 0 Strong Buy Ratings
$100.98
▼ -0.18 (-0.18%)
1 month | 3 months | 12 months
Get New Addus HomeCare Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for ADUS and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for ADUS

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$106.33
▲ +5.30% Upside Potential
This price target is based on 5 analysts offering 12 month price targets for Addus HomeCare in the last 3 months. The average price target is $106.33, with a high forecast of $115.00 and a low forecast of $95.00. The average price target represents a 5.30% upside from the last price of $100.98.
Buy
The current consensus among 5 contributing investment analysts is to buy stock in Addus HomeCare.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 7 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/5/2019
  • 0 strong buy ratings
  • 7 buy ratings
  • 1 hold ratings
  • 0 sell ratings
8/3/2019
  • 0 strong buy ratings
  • 6 buy ratings
  • 1 hold ratings
  • 0 sell ratings
11/1/2019
  • 0 strong buy ratings
  • 7 buy ratings
  • 1 hold ratings
  • 0 sell ratings
1/30/2020
  • 0 strong buy ratings
  • 6 buy ratings
  • 1 hold ratings
  • 0 sell ratings
4/29/2020
  • 0 strong buy ratings
  • 7 buy ratings
  • 1 hold ratings
  • 0 sell ratings
7/28/2020
  • 0 strong buy ratings
  • 6 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/26/2020
  • 0 strong buy ratings
  • 5 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/26/2020

Latest Recommendations

  • 0 strong buy ratings
  • 5 buy ratings
  • 0 hold ratings
  • 0 sell ratings

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
10/1/2020OppenheimerReiterated RatingBuyHigh
i
Rating by Michael Wiederhorn at Oppenheimer Holdings Inc.
8/12/2020BMO Capital MarketsBoost Price Target$103.00 ➝ $115.00High
i
8/11/2020OppenheimerBoost Price TargetOutperform$107.00 ➝ $115.00High
i
Rating by Michael Wiederhorn at Oppenheimer Holdings Inc.
6/17/2020Robert W. BairdBoost Price TargetOutperform$96.00 ➝ $100.00Medium
i
6/1/2020SidotiBoost Price TargetBuy$96.00 ➝ $115.00Low
i
5/6/2020Robert W. BairdBoost Price TargetOutperform$80.00 ➝ $96.00Low
i
5/4/2020OppenheimerReiterated RatingBuy$107.00High
i
4/20/2020Royal Bank of CanadaReiterated RatingBuy$98.00Low
i
3/18/2020SidotiLower Price TargetBuy$115.00 ➝ $96.00High
i
12/10/2019OppenheimerBoost Price Target$96.00 ➝ $107.00Low
i
Rating by Michael Wiederhorn at Oppenheimer Holdings Inc.
11/6/2019Royal Bank of CanadaBoost Price TargetOutperform ➝ Outperform$90.00 ➝ $100.00Low
i
11/6/2019Raymond JamesBoost Price TargetOutperform$92.00 ➝ $95.00Medium
i
Rating by John Ransom at Raymond James
10/21/2019StephensInitiated CoverageOverweight$97.00Low
i
9/17/2019OppenheimerSet Price TargetBuy$91.00Low
i
Rating by Michael Wiederhorn at Oppenheimer Holdings Inc.
8/21/2019SidotiSet Price TargetBuy$115.00N/A
i
Rating by Mitra Ramgopal at Sidoti
8/9/2019William BlairReiterated RatingOutperformHigh
i
Rating by M. Larew at William Blair
8/7/2019BMO Capital MarketsSet Price TargetHold$85.00Medium
i
Rating by Matthew Borsch at BMO Capital Markets
8/7/2019OppenheimerBoost Price TargetBuy$80.00 ➝ $91.00Low
i
8/7/2019Raymond JamesSet Price TargetOutperform$81.00 ➝ $92.00Medium
i
8/6/2019SidotiBoost Price TargetBuy$84.00 ➝ $96.00Medium
i
6/27/2019BMO Capital MarketsInitiated CoverageMarket Perform ➝ Market PerformLow
i
6/13/2019Raymond JamesBoost Price TargetOutperform$75.00 ➝ $81.00High
i
2/4/2019Robert W. BairdUpgradeNeutral ➝ Outperform$72.00 ➝ $75.00High
i
11/7/2018OppenheimerBoost Price TargetOutperform$72.00 ➝ $80.00Low
i
10/8/2018Royal Bank of CanadaInitiated CoverageOutperform ➝ Outperform$81.00Medium
i
9/12/2018Cantor FitzgeraldInitiated CoverageOverweight$77.00Low
i
8/21/2018Jefferies Financial GroupInitiated CoverageBuy$75.00 ➝ $75.00Low
i
8/20/2018Raymond JamesInitiated CoverageOutperform$75.00Low
i
8/8/2018OppenheimerBoost Price TargetOutperform$50.00 ➝ $72.00Low
i
8/8/2018Robert W. BairdReiterated RatingHold$65.00Low
i
Rating by Whit Mayo at Robert W. Baird
8/7/2018StephensBoost Price TargetOverweight$67.00 ➝ $75.00High
i
Rating by Dana Hambly at Stephens
4/2/2018StephensSet Price TargetBuy$56.00Medium
i
Rating by Dana Hambly at Stephens
3/14/2018Robert W. BairdSet Price TargetHold$43.00Low
i
Rating by Whit Mayo at Robert W. Baird
9/19/2017OppenheimerReiterated RatingBuy$45.00Low
i
8/29/2017OppenheimerReiterated RatingBuy$45.00Medium
i
8/24/2017Robert W. BairdReiterated RatingHold$40.00Medium
i
11/10/2016OppenheimerReiterated RatingOutperform$30.00N/A
i
5/16/2016Robert W. BairdReiterated RatingHoldN/A
i
Rating by Whit Mayo at Robert W. Baird
5/3/2016OppenheimerReiterated RatingBuyN/A
i
Rating by Michael Wiederhorn at Oppenheimer Holdings Inc.
3/16/2016Robert W. BairdReiterated RatingNeutral$20.00N/A
i
3/9/2016OppenheimerReiterated RatingOutperformN/A
i
1/19/2016OppenheimerReiterated RatingOutperform$30.00N/A
i
Rating by Michael Wiederhorn at Oppenheimer Holdings Inc.
(Data available from 10/27/2015 forward)
Addus HomeCare logo
Addus HomeCare Corporation provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. It operates in three segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living. This segment's services include assistance with bathing, grooming, oral care, feeding and dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services. The Hospice segment provides palliative nursing care, social work, spiritual counseling, homemaker, and bereavement counseling services for people who are terminally ill, as well as related services for their families. The Home Health segment offers skilled nursing and physical, occupational, and speech therapy for the individuals who requires assistance during an illness or after hospitalization. The company's payor clients include federal, state, and local governmental agencies; managed care organizations; commercial insurers; and private individuals. As of June 30, 2020, the company served consumers through 190 offices located in 25 states. Addus HomeCare Corporation was founded in 1979 and is based in Frisco, Texas.
Read More

Today's Range

Now: $100.98
$99.27
$101.57

50 Day Range

MA: $96.26
$87.82
$103.93

52 Week Range

Now: $100.98
$43.13
$106.98

Volume

88,600 shs

Average Volume

88,804 shs

Market Capitalization

$1.58 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.51